Management of recurrent well-differentiated thyroid carcinoma in the neck: A comprehensive review Review


Authors: Cavalheiro, B. G.; Shah, J. P.; Randolph, G. W.; Medina, J. E.; Tufano, R. P.; Zafereo, M.; Hartl, D. M.; Nixon, I. J.; Guntinas-Lichius, O.; Vander Poorten, V.; López, F.; Khafif, A. H.; Owen, R. P.; Shaha, A.; Rodrigo, J. P.; Rinaldo, A.; Mäkitie, A. A.; Silver, C. E.; Sanabria, A.; Kowalski, L. P.; Ferlito, A.
Review Title: Management of recurrent well-differentiated thyroid carcinoma in the neck: A comprehensive review
Abstract: Surgery has been historically the preferred primary treatment for patients with well-differentiated thyroid carcinoma and for selected locoregional recurrences. Adjuvant therapy with radioactive iodine is typically recommended for patients with an intermediate to high risk of recurrence. Despite these treatments, locally advanced disease and locoregional relapses are not infrequent. These patients have a prolonged overall survival that may result in long periods of active disease and the possibility of requiring subsequent treatments. Recently, many new options have emerged as salvage therapies. This review offers a comprehensive discussion and considerations regarding surgery, active surveillance, radioactive iodine therapy, ultrasonography-guided percutaneous ablation, external beam radiotherapy, and systemic therapy for well-differentiated thyroid cancer based on relevant publications and current reference guidelines. We feel that the surgical member of the thyroid cancer management team is empowered by being aware and facile with all management options. © 2023 by the authors.
Keywords: cancer survival; overall survival; disease course; review; cancer localization; cancer recurrence; neck dissection; cancer risk; systemic therapy; cancer radiotherapy; neoadjuvant therapy; metastasis; radiotherapy; recurrence; practice guideline; radioactive iodine; surgery; clinical decision making; cancer epidemiology; external beam radiotherapy; radiofrequency ablation; thyroid surgery; differentiated thyroid cancer; molecular targeted therapy; papillary thyroid cancer; thyroid neoplasm; cancer prognosis; human
Journal Title: Cancers
Volume: 15
Issue: 3
ISSN: 2072-6694
Publisher: MDPI  
Date Published: 2023-02-01
Start Page: 923
Language: English
DOI: 10.3390/cancers15030923
PROVIDER: scopus
PMCID: PMC9913047
PUBMED: 36765880
DOI/URL:
Notes: Review -- Export Date: 1 March 2023 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jatin P Shah
    717 Shah
Related MSK Work